• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铂类药物在晚期乳腺癌中临床应用的专家共识(2020版)

[Expert consensus on the clinical application of platinums in advanced breast cancer (2020 version)].

出版信息

Zhonghua Zhong Liu Za Zhi. 2021 Feb 23;43(2):167-175. doi: 10.3760/cma.j.cn112152-20201012-00892.

DOI:10.3760/cma.j.cn112152-20201012-00892
PMID:33601480
Abstract

Breast cancer is the most common and fatal malignant tumor in women, which causes great social burden throughout the world. At present, chemotherapy is still the most important treatment manner of advanced breast cancer, and platinum drugs are one of the commonly used chemotherapeutic drugs. Based on the substantial evidence, the expert committee deeply discusses the clinical application of platinum drugs in advanced breast cancer, gives the reasonable suggestions for its clinical usage, effectiveness and adverse effects. This consensus aims to guide physicians to use drugs reasonably and standardize the diagnosis and treatment.

摘要

乳腺癌是女性中最常见且致命的恶性肿瘤,在全球造成了巨大的社会负担。目前,化疗仍是晚期乳腺癌最重要的治疗方式,而铂类药物是常用的化疗药物之一。基于大量证据,专家委员会深入探讨了铂类药物在晚期乳腺癌中的临床应用,对其临床使用、疗效及不良反应给出了合理建议。本共识旨在指导医生合理用药,规范诊疗。

相似文献

1
[Expert consensus on the clinical application of platinums in advanced breast cancer (2020 version)].铂类药物在晚期乳腺癌中临床应用的专家共识(2020版)
Zhonghua Zhong Liu Za Zhi. 2021 Feb 23;43(2):167-175. doi: 10.3760/cma.j.cn112152-20201012-00892.
2
[Guidelines for clinical application of platinum drugs in breast cancer (2023 edition)].《铂类药物在乳腺癌中的临床应用指南(2023年版)》
Zhonghua Zhong Liu Za Zhi. 2023 Dec 23;45(12):1018-1031. doi: 10.3760/cma.j.cn112152-20230427-00186.
3
[Expert consensus on the clinical practice of taxanes for the treatment of breast cancer].[紫杉烷类治疗乳腺癌临床实践专家共识]
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):161-169. doi: 10.3760/cma.j.cn112152-20200121-00051.
4
[Chinese expert consensus on the clinical diagnosis and treatment of advanced breast carcinoma(2018)].《中国晚期乳腺癌临床诊疗专家共识(2018年版)》
Zhonghua Zhong Liu Za Zhi. 2018 Sep 23;40(9):703-713. doi: 10.3760/cma.j.issn.0253-3766.2018.09.013.
5
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).中国晚期乳腺癌临床诊断专家共识(2018 年版)。
Cancer. 2020 Aug 15;126 Suppl 16:3867-3882. doi: 10.1002/cncr.32832.
6
[Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2020 Edition)].《中国晚期乳腺癌临床诊疗指南(2020年版)》
Zhonghua Zhong Liu Za Zhi. 2020 Oct 23;42(10):781-797. doi: 10.3760/cma.j.cn112152-20200817-00747.
7
[Chinese expert consensus on antiangiogenic drugs for advanced non-small cell lung cancer (2020 Edition)].《中国晚期非小细胞肺癌抗血管生成药物专家共识(2020年版)》
Zhonghua Zhong Liu Za Zhi. 2020 Dec 23;42(12):1063-1077. doi: 10.3760/cma.j.cn112152-20200918-00836.
8
Quantitative determination of tumor platinum concentration of patients with advanced Breast, lung, prostate, or colorectal cancers undergone platinum-based chemotherapy.对接受铂类化疗的晚期乳腺癌、肺癌、前列腺癌或结直肠癌患者的肿瘤铂浓度进行定量测定。
J Cancer Res Ther. 2017 Oct-Dec;13(6):930-935. doi: 10.4103/jcrt.JCRT_1224_16.
9
Platinum containing regimens for metastatic breast cancer.用于转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2004(2):CD003374. doi: 10.1002/14651858.CD003374.pub2.
10
Platinum containing regimens for metastatic breast cancer.用于转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2004(3):CD003374. doi: 10.1002/14651858.CD003374.pub3.

引用本文的文献

1
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.一项关于洛铂为基础的化疗方案治疗晚期乳腺癌安全性和有效性的前瞻性、开放标签、多中心IV期临床试验。
Ther Adv Med Oncol. 2022 Oct 24;14:17588359221122715. doi: 10.1177/17588359221122715. eCollection 2022.